| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 9 | 2023 | 51 | 5.270 |
Why?
|
| Mental Disorders | 12 | 2021 | 159 | 3.330 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2023 | 201 | 2.910 |
Why?
|
| Veterans | 7 | 2022 | 75 | 2.230 |
Why?
|
| Homeless Youth | 5 | 2021 | 12 | 2.100 |
Why?
|
| Adolescent | 40 | 2024 | 2076 | 2.090 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 209 | 2.020 |
Why?
|
| Mental Health Services | 6 | 2021 | 56 | 1.910 |
Why?
|
| Humans | 79 | 2024 | 25692 | 1.780 |
Why?
|
| Buprenorphine | 2 | 2023 | 6 | 1.620 |
Why?
|
| Primary Health Care | 4 | 2020 | 91 | 1.530 |
Why?
|
| Antipsychotic Agents | 5 | 2021 | 61 | 1.520 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 87 | 1.500 |
Why?
|
| Prisoners | 6 | 2013 | 13 | 1.430 |
Why?
|
| Research Design | 4 | 2022 | 188 | 1.400 |
Why?
|
| Machine Learning | 6 | 2021 | 68 | 1.390 |
Why?
|
| Juvenile Delinquency | 8 | 2011 | 15 | 1.380 |
Why?
|
| Electronic Health Records | 7 | 2021 | 72 | 1.380 |
Why?
|
| Psychiatry | 2 | 2021 | 13 | 1.340 |
Why?
|
| Gender Identity | 2 | 2021 | 21 | 1.270 |
Why?
|
| Alcoholism | 5 | 2021 | 65 | 1.250 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 35 | 1.180 |
Why?
|
| Child | 17 | 2022 | 1277 | 1.180 |
Why?
|
| Female | 47 | 2024 | 14273 | 1.140 |
Why?
|
| United States | 16 | 2024 | 1943 | 1.110 |
Why?
|
| Aggression | 4 | 2017 | 28 | 1.090 |
Why?
|
| Young Adult | 17 | 2021 | 1855 | 1.080 |
Why?
|
| Child Psychiatry | 3 | 2018 | 11 | 1.070 |
Why?
|
| Male | 44 | 2024 | 13917 | 1.050 |
Why?
|
| Transgender Persons | 3 | 2021 | 20 | 1.030 |
Why?
|
| Behavior, Addictive | 2 | 2023 | 9 | 1.020 |
Why?
|
| Depressive Disorder | 3 | 2019 | 166 | 0.980 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 98 | 0.970 |
Why?
|
| Foster Home Care | 2 | 2017 | 4 | 0.970 |
Why?
|
| Delphi Technique | 2 | 2022 | 24 | 0.930 |
Why?
|
| Telemedicine | 2 | 2024 | 102 | 0.900 |
Why?
|
| Consensus | 2 | 2022 | 90 | 0.890 |
Why?
|
| Natural Language Processing | 5 | 2021 | 7 | 0.890 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 26 | 0.860 |
Why?
|
| Mentoring | 1 | 2023 | 31 | 0.800 |
Why?
|
| Inpatients | 3 | 2020 | 132 | 0.780 |
Why?
|
| Referral and Consultation | 2 | 2020 | 86 | 0.780 |
Why?
|
| Adult | 21 | 2022 | 7336 | 0.770 |
Why?
|
| Length of Stay | 2 | 2020 | 300 | 0.760 |
Why?
|
| National Institute on Drug Abuse (U.S.) | 1 | 2021 | 1 | 0.740 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2021 | 17 | 0.730 |
Why?
|
| Crime Victims | 2 | 2024 | 26 | 0.690 |
Why?
|
| Prescription Drug Misuse | 1 | 2019 | 3 | 0.680 |
Why?
|
| Cultural Diversity | 3 | 2004 | 29 | 0.670 |
Why?
|
| Adolescent Psychiatry | 2 | 2018 | 7 | 0.660 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 245 | 0.660 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 70 | 0.650 |
Why?
|
| Patient Discharge | 1 | 2020 | 136 | 0.650 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2019 | 5 | 0.650 |
Why?
|
| Bullying | 1 | 2019 | 4 | 0.650 |
Why?
|
| Patient Health Questionnaire | 1 | 2019 | 14 | 0.640 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 24 | 0.630 |
Why?
|
| Psychotropic Drugs | 2 | 2017 | 27 | 0.620 |
Why?
|
| Opiate Substitution Treatment | 3 | 2023 | 6 | 0.620 |
Why?
|
| Community Health Centers | 1 | 2018 | 13 | 0.610 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 43 | 0.590 |
Why?
|
| Disclosure | 1 | 2018 | 13 | 0.590 |
Why?
|
| Conflict of Interest | 1 | 2018 | 10 | 0.590 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 71 | 0.590 |
Why?
|
| Bias | 1 | 2018 | 37 | 0.590 |
Why?
|
| Quality of Life | 1 | 2022 | 600 | 0.580 |
Why?
|
| Publishing | 1 | 2018 | 38 | 0.570 |
Why?
|
| Risk-Taking | 2 | 2014 | 22 | 0.570 |
Why?
|
| Drug Discovery | 1 | 2017 | 15 | 0.560 |
Why?
|
| Informed Consent | 1 | 2017 | 21 | 0.550 |
Why?
|
| Social Behavior | 1 | 2017 | 70 | 0.550 |
Why?
|
| Nurse Practitioners | 1 | 2018 | 91 | 0.550 |
Why?
|
| Meaningful Use | 1 | 2016 | 3 | 0.540 |
Why?
|
| Mental Health | 4 | 2021 | 111 | 0.520 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 170 | 0.510 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 209 | 0.510 |
Why?
|
| Psychology, Adolescent | 3 | 2011 | 9 | 0.510 |
Why?
|
| Adolescent Behavior | 3 | 2014 | 31 | 0.500 |
Why?
|
| Social Media | 2 | 2017 | 45 | 0.500 |
Why?
|
| Students, Medical | 3 | 2004 | 47 | 0.500 |
Why?
|
| Violence | 3 | 2024 | 38 | 0.490 |
Why?
|
| Social Support | 2 | 2016 | 188 | 0.490 |
Why?
|
| Antisocial Personality Disorder | 2 | 2011 | 8 | 0.460 |
Why?
|
| Military Personnel | 3 | 2019 | 35 | 0.440 |
Why?
|
| Education, Medical, Graduate | 3 | 2018 | 69 | 0.430 |
Why?
|
| Middle Aged | 13 | 2021 | 8403 | 0.430 |
Why?
|
| Veterans Health | 1 | 2013 | 2 | 0.430 |
Why?
|
| Rape | 1 | 2013 | 5 | 0.420 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 146 | 0.410 |
Why?
|
| Treatment Outcome | 7 | 2022 | 3231 | 0.410 |
Why?
|
| Group Processes | 1 | 2012 | 11 | 0.400 |
Why?
|
| Adolescent Development | 1 | 2012 | 6 | 0.400 |
Why?
|
| Valproic Acid | 2 | 2009 | 12 | 0.400 |
Why?
|
| Minority Groups | 2 | 2024 | 82 | 0.400 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2012 | 16 | 0.390 |
Why?
|
| Family Therapy | 1 | 2011 | 2 | 0.390 |
Why?
|
| Systems Theory | 1 | 2011 | 3 | 0.390 |
Why?
|
| Chicago | 4 | 2019 | 869 | 0.390 |
Why?
|
| Refugees | 4 | 2014 | 22 | 0.390 |
Why?
|
| Child, Preschool | 5 | 2021 | 640 | 0.380 |
Why?
|
| Teaching | 3 | 2010 | 53 | 0.370 |
Why?
|
| Central Nervous System Stimulants | 2 | 2016 | 37 | 0.360 |
Why?
|
| Ethnopsychology | 1 | 2010 | 1 | 0.360 |
Why?
|
| Urban Population | 1 | 2011 | 149 | 0.360 |
Why?
|
| Cultural Competency | 1 | 2010 | 13 | 0.350 |
Why?
|
| Housing | 2 | 2021 | 19 | 0.350 |
Why?
|
| Models, Educational | 1 | 2010 | 30 | 0.350 |
Why?
|
| Criminal Psychology | 1 | 2009 | 1 | 0.320 |
Why?
|
| Criminals | 1 | 2009 | 1 | 0.320 |
Why?
|
| Crime | 1 | 2009 | 7 | 0.320 |
Why?
|
| Patient Readmission | 2 | 2020 | 116 | 0.320 |
Why?
|
| Temperament | 1 | 2009 | 13 | 0.320 |
Why?
|
| Impulsive Behavior | 1 | 2009 | 13 | 0.320 |
Why?
|
| Sexual Behavior | 2 | 2021 | 47 | 0.310 |
Why?
|
| Curriculum | 3 | 2004 | 136 | 0.310 |
Why?
|
| Mass Screening | 2 | 2020 | 168 | 0.310 |
Why?
|
| Character | 1 | 2008 | 3 | 0.310 |
Why?
|
| Infant, Newborn | 2 | 2021 | 588 | 0.300 |
Why?
|
| Mobile Applications | 2 | 2019 | 29 | 0.300 |
Why?
|
| Arousal | 1 | 2008 | 41 | 0.300 |
Why?
|
| Delirium | 1 | 2007 | 13 | 0.280 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2006 | 2 | 0.280 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2006 | 4 | 0.280 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 16 | 0.280 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2006 | 25 | 0.270 |
Why?
|
| Prevalence | 7 | 2014 | 435 | 0.270 |
Why?
|
| Comorbidity | 4 | 2020 | 457 | 0.270 |
Why?
|
| Psychopathology | 1 | 2006 | 6 | 0.270 |
Why?
|
| Self Disclosure | 1 | 2006 | 6 | 0.270 |
Why?
|
| Stress, Psychological | 1 | 2008 | 211 | 0.260 |
Why?
|
| Transaminases | 1 | 2005 | 6 | 0.260 |
Why?
|
| Simvastatin | 1 | 2005 | 14 | 0.250 |
Why?
|
| Rhabdomyolysis | 1 | 2005 | 7 | 0.250 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2005 | 26 | 0.250 |
Why?
|
| Triazoles | 1 | 2005 | 28 | 0.250 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 25 | 0.250 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 84 | 0.250 |
Why?
|
| Prejudice | 2 | 2003 | 31 | 0.240 |
Why?
|
| Algorithms | 1 | 2007 | 347 | 0.240 |
Why?
|
| California | 3 | 2010 | 30 | 0.230 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2004 | 30 | 0.230 |
Why?
|
| Sex Factors | 5 | 2020 | 427 | 0.230 |
Why?
|
| Education, Medical | 1 | 2004 | 39 | 0.230 |
Why?
|
| Pediatrics | 2 | 2020 | 38 | 0.230 |
Why?
|
| Social Problems | 1 | 2023 | 6 | 0.220 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2020 | 20 | 0.220 |
Why?
|
| Students | 1 | 2024 | 46 | 0.220 |
Why?
|
| Ambulatory Care Facilities | 2 | 2020 | 39 | 0.210 |
Why?
|
| Mentors | 1 | 2023 | 40 | 0.210 |
Why?
|
| Self Efficacy | 1 | 2023 | 53 | 0.210 |
Why?
|
| Aged | 6 | 2021 | 8501 | 0.210 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 847 | 0.210 |
Why?
|
| Learning | 1 | 2023 | 67 | 0.200 |
Why?
|
| Mental Processes | 1 | 2022 | 17 | 0.200 |
Why?
|
| Education, Continuing | 1 | 2022 | 13 | 0.190 |
Why?
|
| Internship and Residency | 2 | 2018 | 196 | 0.190 |
Why?
|
| Hospital Mortality | 1 | 2022 | 131 | 0.190 |
Why?
|
| Dementia | 1 | 2006 | 532 | 0.190 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 72 | 0.190 |
Why?
|
| Endpoint Determination | 1 | 2021 | 21 | 0.180 |
Why?
|
| Data Collection | 1 | 2021 | 93 | 0.180 |
Why?
|
| Morals | 1 | 2020 | 4 | 0.180 |
Why?
|
| Patients | 1 | 2021 | 32 | 0.180 |
Why?
|
| Ethanol | 1 | 2021 | 101 | 0.180 |
Why?
|
| Psychotherapy | 1 | 2021 | 38 | 0.180 |
Why?
|
| Surveys and Questionnaires | 8 | 2019 | 1077 | 0.180 |
Why?
|
| Communication | 1 | 2001 | 119 | 0.180 |
Why?
|
| Forecasting | 1 | 2020 | 92 | 0.170 |
Why?
|
| Psychotherapy, Brief | 1 | 2020 | 2 | 0.170 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 26 | 0.170 |
Why?
|
| Social Adjustment | 2 | 2017 | 28 | 0.170 |
Why?
|
| Insurance Coverage | 1 | 2019 | 15 | 0.170 |
Why?
|
| Supervised Machine Learning | 1 | 2019 | 14 | 0.170 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 332 | 0.170 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 15 | 0.160 |
Why?
|
| Trauma Centers | 1 | 2019 | 8 | 0.160 |
Why?
|
| Global Health | 1 | 2019 | 40 | 0.160 |
Why?
|
| Physician-Patient Relations | 2 | 2013 | 37 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2021 | 3220 | 0.160 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 43 | 0.150 |
Why?
|
| Personality Inventory | 2 | 2009 | 74 | 0.150 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 96 | 0.150 |
Why?
|
| Conduct Disorder | 2 | 2009 | 3 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2018 | 20 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 32 | 0.150 |
Why?
|
| Sex Offenses | 1 | 2018 | 18 | 0.150 |
Why?
|
| Hospitalization | 1 | 2020 | 292 | 0.150 |
Why?
|
| Survivors | 1 | 2018 | 67 | 0.150 |
Why?
|
| Infant | 1 | 2019 | 529 | 0.150 |
Why?
|
| Brain | 1 | 2006 | 1560 | 0.140 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 26 | 0.140 |
Why?
|
| Minors | 2 | 2014 | 4 | 0.140 |
Why?
|
| Risk Factors | 5 | 2021 | 2224 | 0.140 |
Why?
|
| Risk | 1 | 2017 | 190 | 0.140 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 153 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2017 | 17 | 0.140 |
Why?
|
| Catheterization, Central Venous | 1 | 2017 | 32 | 0.130 |
Why?
|
| Parents | 1 | 2018 | 117 | 0.130 |
Why?
|
| Psychiatric Nursing | 1 | 2018 | 116 | 0.130 |
Why?
|
| Thrombosis | 1 | 2017 | 48 | 0.130 |
Why?
|
| Sexual and Gender Minorities | 1 | 2016 | 23 | 0.130 |
Why?
|
| Resilience, Psychological | 2 | 2014 | 25 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2017 | 60 | 0.130 |
Why?
|
| Cognition | 2 | 2021 | 1265 | 0.130 |
Why?
|
| HIV Infections | 1 | 2020 | 457 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2020 | 618 | 0.120 |
Why?
|
| Escape Reaction | 1 | 2014 | 1 | 0.110 |
Why?
|
| Feeding and Eating Disorders | 1 | 2014 | 12 | 0.110 |
Why?
|
| Interpersonal Relations | 2 | 2012 | 94 | 0.110 |
Why?
|
| Personality Disorders | 1 | 2013 | 15 | 0.110 |
Why?
|
| Age Factors | 2 | 2020 | 716 | 0.110 |
Why?
|
| United Kingdom | 2 | 2004 | 52 | 0.110 |
Why?
|
| Psychology, Military | 1 | 2013 | 1 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 4459 | 0.110 |
Why?
|
| Repression, Psychology | 1 | 2013 | 3 | 0.110 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 7 | 0.110 |
Why?
|
| Physician's Role | 1 | 2013 | 17 | 0.110 |
Why?
|
| Medical History Taking | 1 | 2013 | 26 | 0.100 |
Why?
|
| Mental Status Schedule | 1 | 2013 | 96 | 0.100 |
Why?
|
| Acrosome | 1 | 1992 | 1 | 0.100 |
Why?
|
| Spermatocytes | 1 | 1992 | 1 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 10 | 0.100 |
Why?
|
| Personality | 1 | 2013 | 51 | 0.100 |
Why?
|
| Mass Behavior | 1 | 2012 | 1 | 0.100 |
Why?
|
| Social Change | 1 | 2012 | 4 | 0.100 |
Why?
|
| Physical Examination | 1 | 2013 | 110 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 913 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2006 | 1176 | 0.100 |
Why?
|
| Animals | 2 | 2017 | 3510 | 0.100 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 34 | 0.090 |
Why?
|
| Psychology | 1 | 2011 | 23 | 0.090 |
Why?
|
| Competency-Based Education | 1 | 2010 | 14 | 0.090 |
Why?
|
| Drug Resistance | 1 | 2009 | 37 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 163 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2019 | 1781 | 0.080 |
Why?
|
| Interview, Psychological | 1 | 2009 | 41 | 0.080 |
Why?
|
| Child, Abandoned | 1 | 2009 | 2 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2019 | 207 | 0.080 |
Why?
|
| Free Association | 1 | 2008 | 1 | 0.080 |
Why?
|
| Austria | 3 | 2014 | 6 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2019 | 116 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 311 | 0.070 |
Why?
|
| Heart Rate | 1 | 2008 | 109 | 0.070 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2007 | 1 | 0.070 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2007 | 4 | 0.070 |
Why?
|
| Risperidone | 1 | 2007 | 4 | 0.070 |
Why?
|
| Haloperidol | 1 | 2007 | 4 | 0.070 |
Why?
|
| Hyperkinesis | 1 | 2007 | 8 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 13 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2007 | 27 | 0.070 |
Why?
|
| Electroshock | 1 | 2006 | 1 | 0.070 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 13 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 51 | 0.070 |
Why?
|
| Tauopathies | 1 | 2006 | 21 | 0.070 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 1 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 29 | 0.070 |
Why?
|
| Atrophy | 1 | 2006 | 88 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 325 | 0.070 |
Why?
|
| Logistic Models | 2 | 2020 | 366 | 0.070 |
Why?
|
| Psychopharmacology | 1 | 2006 | 2 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 69 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 36 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 13 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2019 | 156 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 222 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 341 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 299 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 87 | 0.060 |
Why?
|
| Piperazines | 1 | 2005 | 75 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 126 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 180 | 0.060 |
Why?
|
| Disease Progression | 1 | 2006 | 664 | 0.060 |
Why?
|
| Illinois | 1 | 2004 | 223 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2003 | 59 | 0.050 |
Why?
|
| Life Change Events | 2 | 2014 | 37 | 0.050 |
Why?
|
| Prognosis | 1 | 2006 | 739 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 560 | 0.050 |
Why?
|
| Africa | 2 | 2014 | 11 | 0.050 |
Why?
|
| Warfare | 2 | 2014 | 14 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 698 | 0.050 |
Why?
|
| Parenting | 2 | 2018 | 75 | 0.050 |
Why?
|
| State Medicine | 1 | 2001 | 3 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1084 | 0.050 |
Why?
|
| Unified Medical Language System | 1 | 2020 | 1 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2020 | 6 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 6 | 0.040 |
Why?
|
| Yoga | 1 | 2020 | 7 | 0.040 |
Why?
|
| Medical Records | 1 | 2020 | 31 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mindfulness | 1 | 2020 | 39 | 0.040 |
Why?
|
| Text Messaging | 1 | 2019 | 16 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 119 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 57 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 2019 | 36 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 277 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 117 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 129 | 0.040 |
Why?
|
| Psychometrics | 1 | 2019 | 216 | 0.040 |
Why?
|
| Health Promotion | 1 | 2019 | 140 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 472 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 38 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 392 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 532 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 646 | 0.040 |
Why?
|
| Central Venous Catheters | 1 | 2017 | 2 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 80 | 0.030 |
Why?
|
| India | 1 | 2017 | 21 | 0.030 |
Why?
|
| Research | 1 | 2016 | 38 | 0.030 |
Why?
|
| Methylphenidate | 1 | 2016 | 5 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 37 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 313 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 107 | 0.030 |
Why?
|
| Depression | 1 | 2018 | 412 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 84 | 0.030 |
Why?
|
| Family Relations | 1 | 2014 | 14 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 75 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1992 | 2 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1992 | 3 | 0.030 |
Why?
|
| Spermatids | 1 | 1992 | 2 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 6 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1992 | 8 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 26 | 0.030 |
Why?
|
| Antibodies | 1 | 1992 | 48 | 0.030 |
Why?
|
| Self Report | 1 | 2013 | 204 | 0.020 |
Why?
|
| Yugoslavia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Turkey | 1 | 2011 | 5 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2011 | 21 | 0.020 |
Why?
|
| Motivation | 1 | 2011 | 89 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 305 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1689 | 0.020 |
Why?
|
| Child Welfare | 1 | 2009 | 20 | 0.020 |
Why?
|
| Mice | 1 | 1992 | 1345 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2006 | 11 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2005 | 3 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2005 | 11 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2005 | 37 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2005 | 100 | 0.010 |
Why?
|